1-4 of 4
Marie-Thérèse Daniel
Close
Sort by
Journal Articles

Predictive factors of response and survival in myelodysplastic syndrome treated with erythropoietin and G-CSF: the GFM experience

Clinical Trials & Observations
Sophie Park, Sophie Grabar, Charikleia Kelaidi, Odile Beyne-Rauzy, Françoise Picard, Valérie Bardet, Valérie Coiteux, Geneviève Leroux, Pascale Lepelley, Marie-Thérèse Daniel, Stéphane Cheze, Béatrice Mahé, Augustin Ferrant, Christophe Ravoet, Martine Escoffre-Barbe, Lionel Adès, Norbert Vey, Lina Aljassem, Aspasia Stamatoullas, Lionel Mannone, Hervé Dombret, Keith Bourgeois, Peter Greenberg, Pierre Fenaux, François Dreyfus
Journal: Blood
Blood (2008) 111 (2): 574–582.
https://doi.org/10.1182/blood-2007-06-096370
Published: 2008
Includes: Supplemental data
Journal Articles

Intensive chemotherapy regimen (LMB86) for St Jude stage IV AIDS-related Burkitt lymphoma/leukemia: a prospective study

Clinical Trials & Observations
Lionel Galicier, Claire Fieschi, Raphael Borie, Véronique Meignin, Marie-Thérèse Daniel, Laurence Gérard, Eric Oksenhendler
Journal: Blood
Blood (2007) 110 (8): 2846–2854.
https://doi.org/10.1182/blood-2006-10-051771
Published: 2007
Journal Articles

Sequential Treatment with 5-Azacytidine, Valproic Acid (VPA), and All-Trans Retinoic Acid (ATRA) in Patients with High-Risk Acute Myeloid Leukemia (AML).

Emmanuel Raffoux, Adrienne de Labarthe, Claude Gardin, Marie-Therese Daniel, Christine Chomienne, Pierre Fenaux, Laurent Degos, Herve Dombret
Journal: Blood
Blood (2005) 106 (11): 2798.
https://doi.org/10.1182/blood.V106.11.2798.2798
Published: 2005
Journal Articles

Intensive Chemotherapy (LMB-86 Regimen) for AIDS-Related Burkitt’s Lymphoma/Leukemia.

Lionel Galicier, MD, Claire Fieschi, MD, Laurence Gerard, MD, Sylvie Chevrey, MD, Emmanuelle Boulanger, MD, Marie-Therese Daniel, MD, Veronique Meignin, MD, Eric Oksenhendler, MD
Journal: Blood
Blood (2005) 106 (11): 924.
https://doi.org/10.1182/blood.V106.11.924.924
Published: 2005